Surg Cosmet Dermatol. 2025;17(3):1-11
INTRODUCTION: Cutaneous malignant tumors are preventable and have a high cure rate when diagnosed early, resulting in reduced morbidity and mortality. Early-stage cancer detection allows for timely treatment, leading to a better prognosis.
OBJECTIVE: To evaluate the effectiveness of the "Skin Cancer Awareness Month" campaign in identifying potential cases of skin cancer and its resolution rate based on the time required for lesion treatment.
METHOD: A retrospective analytical cross-sectional study with descriptive-quantitative characteristics.
RESULTS: In 2022, the time between biopsy and curative surgery ranged from 94 to 218 days, with a median of 153 days. In 2023, the time between biopsy and curative surgery ranged from 12 to 249 days, with a median of 129 days. A statistically significant difference (p=0.04) was observed between the years 2022 and 2023 in the median time from biopsy to surgery.
CONCLUSION: Improved efficiency in performing biopsies and surgeries, as well as enhanced patient adherence to treatment, was necessary.
Keywords: Carcinoma; Carcinoma, Squamous Cell; Skin Neoplasms; Health Promotion; Time-to-Treatment.
All content the journal, except where identified, is under a Creative Commons Attribution-NonCommercial 4.0 International license - ISSN-e 1984-8773
